CVS Health (CVS) Tops Q1 EPS by 10c; Trims FY Outlook
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $102.87 +4.63%
EPS Growth %: +1.1%
Financial Fact:
Net loss attributable to noncontrolling interest: -1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +1.1%
Financial Fact:
Net loss attributable to noncontrolling interest: -1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q1 EPS of $2.20, $0.10 better than the analyst estimate of $2.10. Revenue for the quarter came in at $85.3 billion versus the consensus estimate of $80.91 billion.
GUIDANCE:
CVS Health sees FY2023 EPS of $8.50-$8.70, from $8.70-$8.90 and versus the consensus of $8.73.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
- Alphabet slides over 6% as AI brain drain and SpaceX slump converge
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
